Kush M Parmar, Managing Partner at 5AM Ventures, Menlo Park, CA — verified investor profile. See sector focus and contact routes.
Kush M. Parmar, M.D., Ph.D., is the Managing Partner at 5AM Ventures, a life sciences venture capital firm, having joined in 2010 and rising to managing partner in 2015. His investment thesis centers on funding and building next-generation therapeutic companies, primarily at the Series A stage, with a focus on biotechnology, drug discovery, and therapeutic platforms in the USA. The firm’s typical check size ranges from $100,000 to $5 million, and Parmar is known to lead investment rounds. Notable portfolio companies include Entrada Therapeutics, where he serves as Board Chairman since 2016, and Immuneel Therapeutics, a company he co-founded to deliver CAR-T cell therapy for pediatric leukemias in India at significantly lower costs. Parmar brings a distinctive cross-border perspective to life sciences investing, leveraging his background of being born in New Jersey, raised in India, and trained as an NIH-sponsored M.D./Ph.D. physician-scientist at Harvard-MIT to build globally relevant biotech companies. He actively serves on the boards of over a dozen public and private companies in biopharmaceuticals and drug delivery, including Syngene Internation
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Menlo Park when building a target list.
Investors like Kush M Parmar · Full investor directory · Investor access · Company funding database